Expertise in
3
conditions

Zunmin M. Zhu

Zhengzhou, CN 
Clinical Trials:Currently Recruiting for 1 Trial
Expertise in
3
conditions
Zhengzhou, CN 

Overview

Zunmin Zhu practices practicing medicine in Zhengzhou, China.

Zhu is highly rated in 3 conditions, according to our data. Their clinical expertise encompasses Acute Promyelocytic Leukemia, Leukemia, Acute Myeloid Leukemia (AML), Multiple Myeloma, and Bone Marrow Transplant.

They are actively involved in clinical research, co-authoring 77 peer reviewed articles and participating in 2 clinical trials.

Locations

Zhengzhou, 450003, China
Other Locations
Henan, China
Zhengzhou 450003, China Liu Xiaoyin Is Now Working At The First People's Hospital Of Pingdingshan, Pingdingshan, 467099, China

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

A Single-arm, Pivotal Registration Phase II Study of the Efficacy and Safety of APG-2575 Monotherapy in Relapsed or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
A Single-arm, Pivotal Registration Phase II Study of the Efficacy and Safety of APG-2575 Monotherapy in Relapsed or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
Enrollment Status: Recruiting
Publish Date: March 27, 2026
Intervention Type: Drug
Study Drug: APG2575
Study Phase: Phase 2
A Multi-center, Single-arm, Open-label Clinical Study to Evaluate the Efficacy and Safety of HMPL-689 in Patients With Relapsed/Refractory Marginal Zone Lymphoma and Follicular Lymphoma
A Multi-center, Single-arm, Open-label Clinical Study to Evaluate the Efficacy and Safety of HMPL-689 in Patients With Relapsed/Refractory Marginal Zone Lymphoma and Follicular Lymphoma
Enrollment Status: Completed
Publish Date: April 06, 2025
Intervention Type: Drug
Study Drug: HMPL-689
Study Phase: Phase 2
View 1 Less Clinical Trial

77 Total Publications

Clinical and genetic characteristics of patients with mucosa-associated lymphoid tissue lymphoma transformed into diffuse large B-cell lymphoma
Clinical and genetic characteristics of patients with mucosa-associated lymphoid tissue lymphoma transformed into diffuse large B-cell lymphoma
Journal: Zhonghua yi xue za zhi
Published: May 07, 2026

Frequently Asked Questions about Zunmin M. Zhu

Is Zunmin M. Zhu a top-rated expert for Acute Promyelocytic Leukemia?

MediFind is an objective health platform that identifies experts based on real-world data. Zunmin M. Zhu is classified as an Advanced expert for Acute Promyelocytic Leukemia, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Zunmin M. Zhu participate in research or clinical trials?

Yes. Zunmin M. Zhu has published 77 articles and abstracts on conditions like Acute Promyelocytic Leukemia. You can view a list of Zunmin M. Zhu's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Zhu's expertise for a condition
ConditionClose
      View All 24 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile